Trace cannabinoids; what's beyond THC and CBD?

Despite the known benefits of the lesser known cannabis cannabinoid; their small percentage within the plant make it cost prohibitive to extract meaningful quantity.   Dennis O'Neill the President of Biomedican joins Dan Humiston to explain how their patented process helps them produce high quantities of high quality, organic trace cannabinoids.   He discusses their current equity crowdfunding campaign on  WeFunder and how to invest in their company's growth.

Produced by PodCONX

Raising Cannabis Capital - https://podconx.com/podcasts/raising-cannabis-capital

Dan Humiston - https://podconx.com/guests/dan-humiston

Dennis O'Neill - https://podconx.com/guests/dennis-oneill

Biomedican - http://Biomedican.com

WeFunder - https://wefunder.com/biomedican_inc

Produced by PodConx

MJBulls - https://podconx.com/podcasts/raising-cannabis-capital

Dan Humiston - https://www.linkedin.com/in/humiston/

Sound Design - Jamie Humiston - https://www.linkedin.com/in/jamie-humiston-91718b1b3/

Recorded on Squadcast - https://squadcast.fm/